Theravance Biopharma announces shareholder meeting on merger deal - TBPH News | RalliesTheravance Biopharma announces shareholder meeting on merger deal
T
TBPH• Shareholder meeting set for merger vote
- Theravance Biopharma shareholders will meet on Sept. 18, 2026 in South San Francisco, California.
- Vote scheduled on the proposed merger with Zymeworks, which would make Theravance Biopharma a wholly owned Zymeworks subsidiary.
- Ballot also covers approval of the merger agreement and other transactions tied to the deal.
•
